As clinical trials become more complex and decentralized, the role of the CRA is evolving from site monitor to strategic, digitally fluent partner, requiring expertise in hybrid oversight, risk-based monitoring, and multi-system data management.
Helen Yeardley
Advertisement
Senior Vice President, Global Clinical Operations, ICON plc
Articles by Helen Yeardley
Adjusting to the changing dynamics of the clinical research associate role.
Advertisement
Latest Updated Articles
The CRA of the Future: From ‘Road Warrior’ to Site ‘Owner’February 13th 2024
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
4
How AI Is Changing Endpoint Selection Before a Trial Even Starts
5